EDMUND HARRIGAN

Insider Reports History

Location
San Diego, CA
Signature
/s/ Elizabeth Feeney, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by EDMUND HARRIGAN:

Company Role Class Num Shares Value Price $ Report Date Ownership
INCYTE CORP Director Common Stock 20,853 $2,059,650 $98.77 31 Dec 2025 Direct
ACADIA PHARMACEUTICALS INC Director Common Stock 35,041 $611,115 $17.44 29 May 2025 Direct
ACADIA PHARMACEUTICALS INC Director Restricted Stock Units 8,107 $159,016 $16.94 29 May 2025 Direct
ACADIA PHARMACEUTICALS INC Director Director Stock Options (Right to Buy) 13,793 29 May 2025 Direct
PhaseBio Pharmaceuticals Inc Director Common Stock 9,750 19 May 2023 Direct
INCYTE CORP Director Non Qualfied Stock Option (right to buy) 9,216 10 Jun 2025 Direct
PhaseBio Pharmaceuticals Inc Director Restricted Stock Units 0 19 May 2023 Direct

Insider Reports Filed by EDMUND HARRIGAN

Symbol Company Period Transactions Value $ Form Type Role Filing Time
INCY INCYTE CORP 31 Dec 2025 1 +$24,199 4 Director 05 Jan 2026, 16:05
INCY INCYTE CORP 30 Sep 2025 1 +$24,510 4 Director 02 Oct 2025, 16:08
INCY INCYTE CORP 30 Jun 2025 1 +$24,993 4 Director 02 Jul 2025, 16:44
INCY INCYTE CORP 10 Jun 2025 2 $0 4 Director 12 Jun 2025, 16:28
ACAD ACADIA PHARMACEUTICALS INC 29 May 2025 4 $0 4 Director 02 Jun 2025, 18:05
INCY INCYTE CORP 31 Mar 2025 1 +$21,980 4 Director 02 Apr 2025, 16:05
INCY INCYTE CORP 31 Dec 2024 1 +$23,415 4 Director 03 Jan 2025, 13:06
INCY INCYTE CORP 30 Sep 2024 1 +$24,986 4 Director 02 Oct 2024, 13:00
INCY INCYTE CORP 28 Jun 2024 1 +$24,794 4 Director 02 Jul 2024, 13:22
INCY INCYTE CORP 12 Jun 2024 2 $0 4 Director 14 Jun 2024, 12:14
ACAD ACADIA PHARMACEUTICALS INC 29 May 2024 4 $0 4 Director 31 May 2024, 18:00
INCY INCYTE CORP 28 Mar 2024 1 +$23,529 4 Director 02 Apr 2024, 12:12
INCY INCYTE CORP 29 Dec 2023 1 +$26,560 4 Director 03 Jan 2024, 12:07
INCY INCYTE CORP 29 Sep 2023 1 +$22,473 4 Director 03 Oct 2023, 16:06
INCY INCYTE CORP 30 Jun 2023 1 +$24,278 4 Director 05 Jul 2023, 16:01
INCY INCYTE CORP 14 Jun 2023 2 $0 4 Director 16 Jun 2023, 16:00
/report/000116924523000030-harrigan-edmund-2023-05-19 PhaseBio Pharmaceuticals Inc 19 May 2023 2 $0 4 Director 19 May 2023, 16:17
INCY INCYTE CORP 31 Mar 2023 1 +$23,560 4 Director 04 Apr 2023, 16:00
INCY INCYTE CORP 30 Dec 2022 1 +$24,257 4 Director 04 Jan 2023, 15:02
INCY INCYTE CORP 19 Oct 2022 1 +$11,482 4 Director 20 Oct 2022, 16:00
INCY INCYTE CORP 30 Sep 2022 1 +$16,660 4 Director 04 Oct 2022, 16:03
INCY INCYTE CORP 30 Jun 2022 1 +$17,929 4 Director 01 Jul 2022, 16:01
INCY INCYTE CORP 15 Jun 2022 2 $0 4 Director 17 Jun 2022, 16:00
ACAD ACADIA PHARMACEUTICALS INC 07 Jun 2022 2 $0 4 Director 09 Jun 2022, 20:27
/report/000116924522000061-harrigan-edmund-2022-05-19 PhaseBio Pharmaceuticals Inc 19 May 2022 2 $0 4 Director 20 May 2022, 16:44
INCY INCYTE CORP 31 Mar 2022 1 +$19,061 4 Director 04 Apr 2022, 16:00
INCY INCYTE CORP 31 Dec 2021 1 +$18,570 4 Director 04 Jan 2022, 15:17
INCY INCYTE CORP 30 Sep 2021 1 +$16,301 4 Director 04 Oct 2021, 16:36
INCY INCYTE CORP 30 Jun 2021 1 +$17,499 4 Director 02 Jul 2021, 07:32
ACAD ACADIA PHARMACEUTICALS INC 22 Jun 2021 8 $0 4 Director 05 Jun 2023, 21:39
ACAD ACADIA PHARMACEUTICALS INC 22 Jun 2021 2 $0 4 Director 24 Jun 2021, 16:41
/report/000116924521000063-harrigan-edmund-2021-06-03 PhaseBio Pharmaceuticals Inc 03 Jun 2021 1 $0 4 Director 04 Jun 2021, 18:08
INCY INCYTE CORP 26 May 2021 2 $0 4 Director 28 May 2021, 07:14